Streamlining Biotech Data Compliance and Management with Certara’s Phoenix® Cloud Case Study Streamlining Biotech Data Compliance and Management with Certara’s Phoenix® Cloud Discover how Certara's Phoenix Hosted streamlined data compliance and management for a biotech company, enhancing…Certara2024 年 5 月 31 日
Comparative Bioequivalence and Food Effect of Two Formulations of 30-mg Nifedipine Controlled-Release Tablets in Healthy Chinese Adults Publication Comparative Bioequivalence and Food Effect of Two Formulations of 30-mg Nifedipine Controlled-Release Tablets in Healthy Chinese Adults Explore how nifedipine CR formulations are bioequivalent; food reduces exposure modestly, analysed using Phoenix WinNonlin.Certara2024 年 3 月 13 日
Population pharmacokinetic model for oral ORIN1001 in Chinese patients with advanced solid tumors Publication Population pharmacokinetic model for oral ORIN1001 in Chinese patients with advanced solid tumors Discover how PopPK modelling supports dose‑adjustment considerations for ORIN1001 based on bilirubin and lean body…Certara2024 年 3 月 4 日
What is new in Phoenix 8.5? 网络研讨会点播 Phoenix 8.5 有哪些新功能? 了解 Phoenix 8.5 版本的最新进展和增强功能。Watch the webinar to learn…Certara2024 年 2 月 26 日
Guide to development of compound files for PBPK modeling in the Simcyp population-based simulator Publication Simcyp 群体模拟器中 PBPK 建模复合文件开发指南 The Simcyp Simulator is a software platform for population physiologically-based pharmacokinetic (PBPK) modeling and simulation.…Certara2024 年 2 月 23 日
Dose optimization considerations for targeted radiation therapies Blog 靶向放射治疗的剂量优化考量 The acquisitions of targeted radiation therapy companies (TRT) Point Biopharma by Eli Lilly and RayzeBio…Certara2024 年 2 月 16 日
Pharmacokinetic – toxicodynamic Modeling to Elucidate the Involvement of Dorsal Root Ganglion Neuron in Oxaliplatin – induced Peripheral Neurpathu Publication Pharmacokinetic – toxicodynamic Modeling to Elucidate the Involvement of Dorsal Root Ganglion Neuron in Oxaliplatin – induced Peripheral Neurpathu See how DRG‑based PK‑TD modelling predicts neuropathy severity and supports safer oxaliplatin dosing strategies using…Certara2024 年 2 月 1 日
Comparative simulation of intraperitoneal aminoglycoside regimens for patients with peritonitis on automated peritoneal dialysis Publication Comparative simulation of intraperitoneal aminoglycoside regimens for patients with peritonitis on automated peritoneal dialysis Learn how both regimens achieve PK/PD targets; fixed‑dose regimen recommended with trough monitoring, modelled using…Certara2024 年 1 月 30 日
The in vivo study on antioxidant activity of wendan decoction in treating hyperlipidemia: a pharmacokinetic-pharmacodynamic (PK-PD) model Publication The in vivo study on antioxidant activity of wendan decoction in treating hyperlipidemia: a pharmacokinetic-pharmacodynamic (PK-PD) model Find out how PK‑PD modelling shows delayed lipid‑lowering effects driven by key flavonoids in Wendan…Certara2024 年 1 月 23 日
Population Pharmacokinetics and Individualized Medication of Azithromycin for Injection in Children Under 6 Years Old Publication Population Pharmacokinetics and Individualized Medication of Azithromycin for Injection in Children Under 6 Years Old Explore how weight and age drive azithromycin PK variability; PopPK modelling supports personalized dosing using…Certara2024 年 1 月 20 日